image of employees in the office

Portfolio

We are building a diversified portfolio by sector, stage and vintage. We invest in both venture and venture growth funds. Venture funds are typically those investing in early funding stages from pre-seed up to Series A, while venture growth funds invest in Series B onwards.

For more information on each fund manager, please click on the logo below

Abingworth

Stage

Early stage: Seed, Development stage, Clinical co-development

Sectors

Life Sciences

Investment range

$15m - $30m*

*Total investment per company

Active Partners

Stage

Growth, minority or majority investments

Sectors

Consumer, Consumer-tech

Investment range

£3 - 15m

Advent Life Sciences

Stage

Seed, Series A and beyond

Sectors

Life Sciences: Therapeutics and Medtech

Alpina Partners

Stage

Growth

Sectors

Industrials, Software IT, Tech enabled businsess services

Amadeus Capital

Stage

Seed, Series A, Growth

Sectors

Agritech, Artificial Intelligence, Cyber Security, Fintech, Industry 4.0, Medtech, Urban Stack, Quantum Computing

Investment range

£500,000 - £5m

Atlantic Bridge

Stage

Growth stage, Series B and beyond

Sectors

Artificial Intelligence, Augmented Reality, Cloud Infrastructure, Digital Health, Industry 4.0, Network Security

Investment range

€5m - €15m

Atomico

Stage

Series A and beyond

Sectors

Sector agnostic

Balderton Capital

Stage

Series A and beyond

Sectors

Creative Entertainment, Efficient mobility, Enterprise Software, Data-Driven Health, Fintech, Future of Food, Retail, Security

Connect Ventures

Stage

Seed

Sectors

B2B and Consumer Software

Investment range

£750k - £2m

Crane Capital

Stage

Early stage

Sectors

Deeptech, Entreprise Software

Investment range

£1m to £3m

Dawn

Stage

Series A and B

Sectors

B2B software: Data & Analytics, Fintech, Future of Work, Privacy & Security

Investment range

$3m - $25m

Dementia Discovery Fund

Stage

Early stage focus, flexibiltiy to invest at Later stage

Sectors

Therapeutics for all forms of dementias

Draper Esprit

Stage

Series A and beyond

Sectors

Consumer technology, Digital Health & Wellness, Hardware & Deeptech, SaaS and Enterprise

Investment range

£5m - £50m

ETF Partners

Stage

Venture Growth: Series A and B

Sectors

Digital Sustainability: Energy Transition, Green Networks, Future Consumer, Mobility, Sustainable Food

Investment range

£2-10m*

*Total investment per company

Evolution Equity Partners

Stage

Early Growth and Growth

Sectors

Artificial Intelligence/Machine Learning, Cybersecurity, Enterprise Software

Investment range

$1m - $30m

FPE Capital

Stage

Growth stage, businesses at breakeven or beyond

Sectors

Software and Services

Investment range

£5 - 20m

Frog Capital

Stage

Series B, Series C and beyond

Sectors

Software including: Artifical Intelligence & Data Applications, Cloud Technology, Digital Health & Wellbeing, Enterprise SaaS, Hrtech, Fintech, Regtech

Investment range

£5-15m

Hoxton ventures

Stage

Early stage

Sectors

Agonostic providing there is a tech component

Investment range

$250m to $5m

IQ Capital

Stage

Seed and Series A

Sectors

Deeptech including: Artificial Intelligence & Machine learning, Cyber Security, Data Analytics, Fintech, Internet of Things, Performance engineering

Investment range

£300k to £5m

Kennett

Stage

Growth

Sectors

B2B Software

Investment range

£7 - £25m

kester

Stage

Growth

Sectors

Business & Financial Services, Healthcare, Specialist Consumer, TMT

Kindred

Stage

Seed

Sectors

Technology driven companies

Investment range

£500k - £1.5m

MVM Partners

Stage

Growth

Sectors

Healthcare including: Diagnostics, HIT and tech enabled services, Medical Devices, Pharma

Nauta Capital

Stage

Late Seed and Series A

Sectors

B2B SaaS, Deeptech applied to large enterprises, Vertically focused enterprise technology

Investment range

€1 - €5m

Notion Capital

Stage

Early

Sectors

Entreprise technology, SaaS

Investment range

£2 - £10m

OXX

Stage

Scale-up

Sectors

B2B SaaS

Investment range

$5 - 25m

Panoramic

Stage

Growth

Sectors

Agnostic with a focus on busienesses generating £1m+ of revenues

Investment range

£1m - £5m

Passion Capital

Stage

Pre-seed and seed

Sectors

B2B and B2C Digital Technology

Investment range

£200, 000 - £500, 000

Prime ventures

Stage

Growth

Sectors

B2B Software, Consumer, High-Tech

Investment range

€15 - 25m

Scottish Equity Partners

Stage

Growth stage

Sectors

Software, Consumer Internet, Tech-enabled services

Investment range

£10m - £25m

Seedcamp

Stage

Pre-seed and seed

Sectors

Agnostic

Investment range

£200, 000 (pre-seed), up to £500, 000 at seed

SV health investors

Stage

Early, with a focus on company creation*

Sectors

Biotech**

*SV Health Incestors follow their companies and invest through their life cycles including through to clinical stage and IPO
**SV7 Impact Medicine Fund

UCL technology fund

Stage

Early

Sectors

Life sciences, physical sciences, engineering

Investment range

£100,000 - £6m

Westbridge

Stage

Small cap private equity, buy and builds

Sectors

B2B and technology enabled companies

Investment range

£10m - £15m

The information has been supplied by each fund manager. British Patient Capital makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any such data or information. The information is for information only.

In cases where fund managers have different strategies for different funds, the information refers to the funds to which British Patient Capital has made commitments.

The investment range typically refers to the amount at first investment, not the full amount that may be invested through further funding rounds, or by other investors that may join in a funding round.

For full information see the website terms and conditions